Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre

British Journal of Radiology

Volumn 84, Issue 1000, 2011, Pages 358-366

  Chatterjee, Sanjoy ^a   Mott, J H ^a   Smyth, G ^a   Dickson, S ^a   Dobrowsky, W ^a   Kelly, C G ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MEGAVOLTAGE RADIATION; RADIATION DOSE; TOMOTHERAPY; TREATMENT PLANNING; UNITED KINGDOM;

CANCER CARE FACILITIES; CARCINOMA, SQUAMOUS CELL; FEMALE; GREAT BRITAIN; HEAD AND NECK NEOPLASMS; HUMANS; MALE; ORGANS AT RISK; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETREATMENT; TOMOGRAPHY, SPIRAL COMPUTED; WEIGHT LOSS;

EID: 79952776705     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/19586137     Document Type: Article

References (35)

1. Bhide S, Clark C,Harrington K,Nutting C. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Med Dosim 2007;32:188-95.
2. Ahmed M, Hansen VN, Harrington KJ, Nutting CM. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med Dosim 2009;34:217-24.
3. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 2007;29:387-400. (Pubitemid 46623504)
4. Mackie TR. History of tomotherapy. Phys Med Biol 2006;51:R427-53.
5. Beavis AW. Is tomotherapy the future of IMRT? Br J Radiol 2004;77:285-95.
6. Chen AM, Jennelle RL, Sreeraman R, Yang CC, Liu T, Vijayakumar S, et al. Initial clinical experience with helical tomotherapy for head and neck cancer. Head Neck 2009;31:1571-8.
7. Ulrich S, Sterzing F, Nill S, Schubert K, Herfarth KK, Debus J, et al. Comparison of arc-modulated cone beam therapy and helical tomotherapy for three different types of cancer. Med Phys 2009;36:4702-10.
8. Rao M, Yang W, Chen F, Sheng K, Ye J, Mehta V, et al. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. Med Phys 2010;37:1350-59.
9. Ling C, Zhang P, Archambault Y, Bocanek J, Tang G, Losasso T. Commissioning and quality assurance of rapidarc radiotherapy delivery system. Int J Radiat Oncol Biol Phys 2008;72:575-81.
10. Mehta M, Hoban P, Mackie TR. Commissioning and quality assurance of RapidArc radiotherapy delivery system: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72;575-81): absence of data does not constitute proof; the proof is in tasting the pudding. Int J Radiat Oncol Biol Phys 2009;75:4-6.
11. Mohan R. Dueling technologies: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72:575-81). Int J Radiat Oncol Biol Phys 2009;75:6-7.
12. Ling CC, Archambault Y, Bocanek J, Ling CC, Zhang P, LoSasso T, et al. Scylla and charybdis: longer beam-on time or lesser conformality - the dilemma of tomotherapy. Int J Radiat Oncol Biol Phys 2009;75:8-9.
13. Lee TF, Fang FM, Chao PJ, Su TJ, Wang LK, Leung SW. Dosimetric comparisons of helical tomotherapy and stepand-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol 2008;89:89-96.
14. UK Clinical Research Network: Portfolio DatabaseMREC No: 08/H0907/127, UKCRN ID 7341. Chatterjee S (Chief investigator). VortigERN: variation of radiotherapy target volume definition, dose to organs at risk (OAR) and clinical target volumes using anatomic (CT) vs. combined anatomic and molecular imaging (PET-CT): intensity modulated radiotherapy delivered using a tomotherapy Hi Art machine. (Cited 4 Jan 2010). Available from: http://public.ukcrn.org.uk/search/ StudyDetail.aspx?StudyID57341
15. Grégoire V, Levendag P, Ang Kian K, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines: Radiother Oncol 2003;69:227-36.
16. Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006;79:15-20.
17. Prescribing, recording and reporting photon beam therapy. (Supplement to ICRU Report 50). ICRU Report 62. Bethesda, MD: ICRU, 1999.
18. Reddy NM, Mazur AK, Sampath S, Osian A, Sood BM, Ravi A, et al. The potential for dose dumping in normal tissues with IMRT for pelvic and H&N cancers. Med Dosim 2008;33:55-61. (Pubitemid 351192300)
19. Soisson ET, Tomé WA, Richards GM, Mehta MP. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors: Radiother Oncol 2006;78:313-21.
20. Kissick MW, Fenwick J, James JA, Jeraj R, Kapatoes JM, et al. The helical tomotherapy thread effect. Med Phys 2005;32:1414-23. (Pubitemid 40695784)
21. Schubert LK, Westerly DC, Tomé WA, Mehta MP, Soisson ET, Mackie TR, et al. A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments. Int J Radiat Oncol Biol Phys 2009;73:1260-9.
22. Chatterjee S, Mott J, Dickson S, Kelly CG. Extensive basal cell carcinoma of the forehead and anterior scalp: use of helical tomotherapy as a radiotherapy treatment modality (Letter to Editor). Br J Radio. 2010;83:538-40.
23. Sterzing F, Uhl M, Hauswald H, Schubert K, Sroka-Perez G, Chen Y, et al. Dynamic jaws and dynamic couch in helical tomotherapy. Int J Radiat Oncol Biol Phys (in press).
24. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52. (Pubitemid 38580197)
25. Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009;73:399-409.
26. Popovtzer A, Gluck I, Chepeha DB, Teknos TN, Moyer JS, Prince ME, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 2009;74:1342-7.
27. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64:333-42. (Pubitemid 43083417)
28. Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M, Ringash J. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 2008;89:287-91.
29. van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJ, Rasch CR. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41.
30. Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:663-73. (Pubitemid 38221119)
31. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70. (Pubitemid 36959739)
32. Whitelaw GL, Blasiak-Wal I, Cooke K, Usher C, Macdougall ND, Plowman PN. A dosimetric comparison between two intensity-modulated radiotherapy techniques: tomotherapy vs dynamic linear accelerator. Br J Radiol 2008;81:333-40. (Pubitemid 351702963)
33. Rosenthal DI, Asper JA, Barker JL, Jr, Garden AS, Chao KS, Morrison WH, et al. Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head Neck 2006;28:967-73. (Pubitemid 44630935)
34. Sanguineti G, Gunn GB, Endres EJ, Chaljub G, Cheruvu P, Parker B. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008;72:737-46.
35. Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007;85:36-41. (Pubitemid 47570062)